E1. Drugs acting on glucose metabolism Flashcards

1
Q

Look at slides 3 – 10 review of glucose metabolism.

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
What cells are involved in the making of insulin?
A. Alpha cells
B. Beta cells 
C. F cells 
D. Delta cells
A

B. Beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
What cells are involved in the making of glucagon?
A. Alpha cells
B. Beta cells 
C. F cells 
D. Delta cells
A

A. Alpha cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
What cells are responsible for somatostatin?
A. Alpha cells
B. Beta cells 
C. F cells 
D. Delta cells
A

D. Delta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
What cells are responsible for pancreatic polypeptide?
A. Alpha cells
B. Beta cells 
C. F cells 
D. Delta cells
A

C. F cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can cause the stimulation of insulin secretion?

A
– Rise in blood glucose concentration
– G.I. hormones:
– – gastric, CCK, secretin, gastric inhibitory polypeptide, glucagon
– amino acids and fatty acids in the GIT
– vagal stimulation (M receptors)
– – catcholamines  (beta-2 receptors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Whatcauses the inhibition of insulin secretion?

A

– decrease in blood glucose concentration
– somatostatin
– catecholamines (a2 or I3 receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens if you have too much insulin?

Too little insulin?

A

Too much: hypoglycemia

too little: hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the differentials for hypoglycemia? (5 main, 4 of which have subs)

A
  1. artifact
  2. Unable to make glucose
    – liver failure/cirrhosis
    – Portosystemic shunt
    – severe malnutrition (neonates/toy breeds)
    – hyperadrenocorticism (pituitary/GH deficiency)
    – glycogen storage diseases
  3. Excessive consumption
    – sepsis
    – extreme exertion
  4. Exogenous hypoglycemic agents
    – insulin overdose
    – overdose of other hypoglycemic agents (e.g.. glipizide)
  5. Endogenous hypoglycemic agents
    – xylitol toxicity (dogs)
    – insulin secreting islet cells neoplasia (insulinoma)
    – extrapancreatic neoplasia
    – islet cell hyperplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two main therapeutic considerations for hypoglycemia? (Gen.)

A

Not involving insulin, and involving insulin.

*Look at slide 13 for subcategories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the three main pharmacologic therapy for hypoglycemia?

A

– Replacement
– diet
–Anti-hypoglycemic agents
*look at slide 14 subcategories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is glucagon commonly used to treat hypoglycemia? What’s the initial dilution you should start off with?

A

Not commonly used. Initial dose should be 50 ng/kg followed by 10 – 15 ng/kg/minute.
*adjust based on blood glucose measurement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the proper dose if using dextrose for an acute case or maintenance?

A

Acute: 1 mL/kg of 50% dextrose diluted (1:4)

maintenance:
- 2.5-5% dextrose IV
- Adjust based on blood glucose levels

*don’t want to use greater than 5% dextrose because greater than that will cause phlebitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some considerations you should take into account when using dextrose to treat hypoglycemia? (2)

A

– Hyperosmolality/irritation

– rising glucose stimulates insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

You use dietary management to treat acute and chronic hypoglycemia?

A

Acute: Karo syrup/corn syrup (mostly used outside of clinic, as good as dextrose in an emergency situation)

chronic:
– frequent, small meals
– complex carbs  (symbol carbs may stimulate insulin secretion)
– easily digestible
– moderate fat and protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can use pharmacologic therapy to treat hypoglycemia?

What is the goal of this therapy?

A

glucocorticoids
– Diazoxide
– Streptozotocin
– somatostatin

Goal is to eliminate/minimize clinical signs associated with hypoglycemia (this may not be maintaining a “normal” blood glucose!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the DOC/ reached for first drug to treat hypoglycemia?

A

Glucocorticoids (prednisone, prednisolone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What do glucocorticoids do to the gluconeogenesis, glucose uptake (in tissue), and glucagon secretion?

A

Increase gluconeogenesis, decreased glucose uptake into tissue, stimulate glucagon secretion

19
Q

What is the bioavailability of glucocorticoids is taken orally?

A

Good oral bioavailability

20
Q

Where does prednisone and prednisolone need to go to be activated? (Organ)

A

The liver/hepatic metabolism is required

21
Q

What dose should you start off with when using prednisone or prednisolone?S

A

.5 mg/kg/day, increase as needed

22
Q

What are the side effects of using prednisone or prednisolone?

A

Generally mild at low doses (PU/PD, panting) and get progressively more severe as this is increased (immunosuppression, etc.).

23
Q

What are the drugs that can be used to treat hypoglycemia?

A

Diazoxide, somatostatin, octreotide (somatostatin analog), streptozotocin

24
Q

How do you give Diazoxide?
When should you give this?
What are its side effects?

A

– Oral
– when glucocorticoids and diet longer work
– side effects:
paper celebration, anorexia/vomiting/diarrhea, less commonly (tachycardia, hematologic changes, diabetes, fluid retention)
look at slide 19 and 20 for more information. Slide 20 gives the mode of action.

25
Q

What does somatostatin do?

A

Inhibits release of insulin, glucagon, growth hormone, CCK, secretin, gastrin, VIP

26
Q

What is octreotide sometimes used to treat? (Dogs, ferrets, cats)

A
27
Q

Look at slide 22 for information on streptozotocin.

A

.

28
Q

What are the differential for hyperglycemia? (7)

A

Physiologic hyperglycemia(Stress, postprandial, Diestrus), diabetes mellitus, hypersdrenocorticism, Pheochromocytoma, Pancreatitis/Exocrine Pancreatic Neoplasia, Some Drugs/Toxins, Head Trauma

29
Q

What are the two types of diabetes mellitus?

A

Type I: insulin-dependent (IDDM) (insulin deficiency)
Type II: non-insulin-dependent (NIDDM)(insulin resistance
*type II seen in cats

*Look at slide 25 for a bit more info. Two

30
Q

Look at the slides 26-28.

A

.

31
Q

What is the goal of therapy referring to hyperglycemia?

A

– Reduce hyperglycemia
– reverse catabolic effects
– reverse ketosis
– control clinical signs

*look at slide 29 for more info

32
Q

What are the three general treatments for diabetes mellitus? (All three have subcategories)

A

– General management

33
Q

How does acarbose (Precose) work?

A

It is not a hypoglycemic agents. It inhibits alpha amylase and brush border oligo/disaccharides.

*look at slide 31

34
Q

What are the three types of oral hypoglycemics?

A

Sulfonylureas, Biguanides,

35
Q

Name the drugs that are Sulfonylureas? (only first 2 really matter)

A
36
Q

What is the main thing that Glipizide does?

A

Increased release of insulin

*look at slide 34

37
Q

What is the drug that is considered a Biguanides?

What are the two biggest things you need to know about that drug?

A

Metformin

recognizes as an anti-hyperglycemic that doesn’t affect insulin secretion

*look at slide 35

38
Q

Look at slide 36-39.

A

.

39
Q

What are the two types of insulin that can be given to animals? What is the concentration? T

A
40
Q

How should you properly store and handle insulin?

A
41
Q

What are the types of insulin? (Duration/acting period)

A

Short, intermediate and long

look at slide 42

42
Q

How can short acting insulin be given?

When is this most commonly used

A

IV, IM, SC

most commonly used for DKA management

look at slide 43

43
Q

Look at slide 44-51.

A

.